HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Janet L Anderl Selected Research
Janet L Anderl Research Topics
Disease
4
Neoplasms (Cancer)
11/2017 - 05/2014
2
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2023 - 01/2021
2
Rheumatoid Arthritis
01/2023 - 01/2021
2
Autoimmune Diseases (Autoimmune Disease)
04/2017 - 01/2013
2
Multiple Myeloma
12/2014 - 05/2011
2
Hematologic Neoplasms (Hematological Malignancy)
07/2014 - 05/2014
2
Leukemia
07/2014 - 05/2014
1
Lupus Nephritis
01/2023
1
Proteinuria
01/2023
1
Rheumatic Diseases (Rheumatism)
12/2018
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2014
1
Lung Neoplasms (Lung Cancer)
12/2014
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2014
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2014
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2013
1
Peripheral Nervous System Diseases (PNS Diseases)
05/2011
Drug/Important Bio-Agent (IBA)
5
Bortezomib (Velcade)
FDA Link
04/2017 - 05/2011
3
KZR-616
IBA
01/2023 - 12/2018
3
Proteasome Inhibitors
IBA
12/2014 - 01/2013
3
Proteasome Endopeptidase Complex (Proteasome)
IBA
12/2014 - 05/2011
2
Cytokines
IBA
01/2023 - 11/2017
2
carfilzomib
IBA
04/2017 - 12/2014
1
Histocompatibility Antigens Class I
IBA
11/2017
1
Cisplatin (Platino)
FDA Link
Generic
12/2014
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
12/2014
1
Caspase 3 (Caspase-3)
IBA
12/2014
1
marizomib
IBA
07/2014
1
antineoplaston A10 (A 10)
IBA
05/2014
1
Rituximab (Mabthera)
FDA Link
01/2013
1
Dipeptides
IBA
05/2011